FXYD5 Antibody

說明書

中文名稱：

FXYD5兔多克隆抗體
貨號：

CSB-PA842655DSR1HU
規(guī)格：

￥440
圖片：
Immunohistochemistry of paraffin-embedded human cervical cancer using CSB-PA842655DSR1HU at dilution of 1:100

Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA842655DSR1HU at dilution of 1:100
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) FXYD5 Polyclonal antibody
Uniprot No.：

Q96DB9
基因名：

FXYD5
別名：

FXYD5 antibody; DYSAD antibody; IWU1 antibody; HSPC113 antibody; UNQ2561/PRO6241FXYD domain-containing ion transport regulator 5 antibody; Dysadherin antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human FXYD domain-containing ion transport regulator 5 protein (22-145AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

Antigen Affinity Purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
產品提供形式：

Liquid
應用范圍：

ELISA, IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Involved in down-regulation of E-cadherin which results in reduced cell adhesion. Promotes metastasis.
基因功能參考文獻：
1. the ratio between FXYD5 and alpha1-beta1 heterodimer determines whether the Na,K-ATPase acts as a positive or negative regulator of intercellular adhesion. PMID: 27142834
2. Knockdown of FXYD5 in MDA-MB-231 breast cancer cells largely decreases expression and secretion of the chemokine CCL2 (MCP-1). A related effect has also been observed in renal cell carcinoma cells. PMID: 27006401
3. Study demonstrated that the expression of FXYD1, FXYD3 and FXYD5 is elevated in the lungs of Acute respiratory distress syndrome patients PMID: 26410457
4. Dysadherin-silenced side population cells exhibited reduced expression of Bcl-2 and Bax compared with that prior to silencing. PMID: 26458963
5. we are focusing on the role of dysadherin in E-cadherin downregulation, the various expression patterns of the molecule in head and neck cancer PMID: 22105147
6. Findings suggest that dysadherin might contribute to breast cancer progression through AKT activation. PMID: 22494103
7. These results suggest a role of let-7a down-regulation in the development of thyroid neoplasias of the follicular histotype, likely regulating dysadherin protein expression levels. PMID: 22965940
8. Data show that osteoblasts are the major cell type of the bone marrow that affect RCC cells by secreting factors that increase the expression of dysadherin and CCL2 in the tumor cells leading to enhanced cell migration. PMID: 21328336
9. This is the first report on expression of dysadherin in the male gonad and in spermatozoa. PMID: 21774927
10. Overexpression of Snail, Slug, and dysadherin and activation of Wnt and PI3K/Akt signaling was associated with inactivated E-cadherin in the spindle cells of monophasic fibrous synovial sarcomas. PMID: 21809991
11. Combined dysadherin-positive expression and E-cadherin-negative expression may be valuable information for predicting aggressive tumor behavior of differentiated-type gastric carcinoma with submucosal invasion PMID: 21239043
12. transfection of dysadherin cDNA into the liver cancer cell line PLC/PRF/5 enhanced the properties of cencer stem cells, including anti-apoptosis, their sphere-forming ability, side population phenotype, and tumor initiation ability in vivo PMID: 20952084
13. In lung carcinomas dysadherin expression seems to reflect tumour aggressiveness and may be considered a positive marker of poor prognosis when considered alone or/and in combination with down-regulation of E-cadherin. PMID: 20712010
14. The detection of dysadherin in tumors and cytokeratin in the lymph nodes may be a potential significant indicator of a poor prognosis for patients who undergo complete resection of stage I non-small cell lung cancer PMID: 20944097
15. We report the cloning and characterization of a cancer-associated cell membrane glycoprotein recognized by mAb NCC-3G10. PMID: 11756660
16. dysadherin expression was significantly associated with the prognosis, occurrence of secondary undifferentiated carcinomas, size of the primary tumor, and metastasis to the regional lymph nodes and lungs PMID: 12970317
17. dysadherin has a role in hematogenous metastasis of gastric cancer PMID: 15102690
18. Dysadherin and E-cadherin expression may help to predict the prognosis of patients with ESCC (esophageal squamous cell carcinoma). PMID: 15459499
19. Dysadherin is able to modulate actin structures, stimulate cell motility, and contribute directly to the metastatic potential of human pancreatic cancer cells. PMID: 15466191
20. dysadherin may be a valuable prognostic marker in cervical carcinoma. PMID: 15619642
21. Over expression of dysadherin is associated with cutaneous malignant melanoma PMID: 15751018
22. In testicular tumours, as in other neoplasms, dysadherin downregulates E-cadherin expression, at least in part PMID: 16333245
23. Found in trophoblasts in both normal and abnormal pregnancies. PMID: 17084448
24. Dysadherin may play an important role in breast cancer progression by promoting invasion. PMID: 17437014
25. Recent work that has provided insights into possible mechanisms of action of dysadherin in the cancer progression process was reviewed. PMID: 17442482
26. FXYD5 is upregulated in cystic fibrosis epithelia which may exacerbate the Na(+) hyperabsorption and surface liquid dehydration observed in cystic fibrosis. PMID: 18263667
27. Increased dysadherin expression is possibly one of the post-transcriptional mechanisms responsible for E-cadherin downregulation in thyroid papillary neoplasia PMID: 18677652
28. The dysadherin expression level was significantly correlated with gastrointestinal stromal tumor risk stratification. PMID: 19217217
顯示更多

收起更多
亞細胞定位：

Membrane; Single-pass type I membrane protein.
蛋白家族：

FXYD family
數(shù)據(jù)庫鏈接：

HGNC: 4029

OMIM: 606669

KEGG: hsa:53827

STRING: 9606.ENSP00000344254

UniGene: Hs.333418

Most popular with customers

YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human